Search

Author/Creator Hamed, Mohammed I. A.

1. Design, synthesis, anticancer evaluation, and molecular modelling studies of novel tolmetin derivatives as potential VEGFR-2 inhibitors and apoptosis inducers. (1st January 2021)

Authors:
Kassab, Asmaa E.; Gedawy, Ehab M.; Hamed, Mohammed I. A.; Doghish, Ahmed S.; Hassan, Rasha A.
Journal:
Journal of enzyme inhibition and medicinal chemistry
Issue:
Volume 36:Number 1(2021)
Page Start:
922
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Discovery of oxindole‐based FLT3 inhibitors as a promising therapeutic lead for acute myeloid leukemia carrying the oncogenic ITD mutation. Issue 2 (20th November 2022)

Authors:
Bender, Onur; Shoman, Mai E.; Ali, Taha F. S.; Dogan, Rumeysa; Celik, Ismail; Mollica, Adriano; Hamed, Mohammed I. A.; Aly, Omar M.; Alamri, Abdulwahab; Alanazi, Jowaher; Ahemad, Nafees; Gan, Siew Hua; Malik, Jonaid Ahmad; Anwar, Sirajudheen; Atalay, Arzu; Beshr, Eman A. M.
Journal:
Archiv der Pharmazie
Issue:
Volume 356:Issue 2(2023)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. In a search for potential drug candidates for combating COVID-19: computational study revealed salvianolic acid B as a potential therapeutic targeting 3CLpro and spike proteins. Issue 19 (15th November 2022)

Authors:
Elmaaty, Ayman Abo; Darwish, Khaled M.; Khattab, Muhammad; Elhady, Sameh S.; Salah, Mohammed; Hamed, Mohammed I. A.; Al‐Karmalawy, Ahmed A.; Saleh, Moustafa M.
Journal:
Journal of biomolecular structure & dynamics
Issue:
Volume 40:Issue 19(2022)
Page Start:
8866
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Repurposing levocetirizine hydrochloride loaded into cationic ceramide/phospholipid composite (CCPCs) for management of alopecia: central composite design optimization, in- silico and in-vivo studies. (31st December 2022)

Authors:
Albash, Rofida; El-Dahmy, Rania Moataz; Hamed, Mohammed I. A.; Darwish, Khaled M.; Alahdal, Abdulrahman M.; Kassem, Amira B.; Fahmy, Abdurrahman M.
Journal:
Drug delivery
Issue:
Volume 29:Number 1(2022)
Page Start:
2784
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Repurposing levocetirizine hydrochloride loaded into cationic ceramide/phospholipid composite (CCPCs) for management of alopecia: central composite design optimization, in- silico and in-vivo studies. (31st December 2022)

Authors:
Albash, Rofida; El-Dahmy, Rania Moataz; Hamed, Mohammed I. A.; Darwish, Khaled M.; Alahdal, Abdulrahman M.; Kassem, Amira B.; Fahmy, Abdurrahman M.
Journal:
Drug delivery
Issue:
Volume 29:Number 1(2022)
Page Start:
2784
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Β-Blockers bearing hydroxyethylamine and hydroxyethylene as potential SARS-CoV-2 Mpro inhibitors: rational based design, in silico, in vitro, and SAR studies for lead optimization. Issue 56 (3rd November 2021)

Authors:
Hamed, Mohammed I. A.; Darwish, Khaled M.; Soltane, Raya; Chrouda, Amani; Mostafa, Ahmed; Abo Shama, Noura M.; Elhady, Sameh S.; Abulkhair, Hamada S.; Khodir, Ahmed E.; Elmaaty, Ayman Abo; Al-karmalawy, Ahmed A.
Journal:
RSC advances
Issue:
Volume 11:Issue 56(2021)
Page Start:
35536
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗